Physicians, Case Managers, and HCV Patients Recommend a Simplified Strategy for Baseline Testing and Minimal Monitoring for Treatment of Hepatitis C Virus Infection with DAA Therapies
Effectiveness of ReLink Initiatives to Re-engage Diagnosed-but-Untreated HCV-Positive Patients with Direct-Acting Antiviral Treatment
Improving Validity of Hepatic Venous Pressure Gradient Measurements (Hvpg): A Quality Improvement Project
Acute on Chronic Liver failure is associated with prolonged clot initiation in Rotational Thromboelastometry as compared to Acute Decompensation, but clot formation time and firmness are similar.
A Comparison of Surveillance Strategies for the Early Detection of Hepatocellular Carcinoma: A Case Control Study
Comparison of hepatitis B reactivation in patients with resolved hepatitis B infection receiving rituximab or non-rituximab based immunosuppressive therapy. Does the presence of hepatitis b surface antibody reduce risk of reactivation?
Increased Myostatin/Skeletal Mass Index Ratio is a Predictor of Worse Survival in Hepatitis B Virus-related Liver Cirrhosis
Comparative Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Tenofovir- or Entecavir-Based Regimens: A Meta-Analysis Using Individual Patient Data
Clinical outcomes of variceal and non-variceal upper gastrointestinal bleeding in patients with liver cirrhosis
